Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.
Source:http://linkedlifedata.com/resource/pubmed/id/11733393
Circulation
2001
Dec
4
104
23
2772-7
